CD274 and melanoma: PD-L1, largely induced locally at the tumor by tumor-infiltrating lymphocytes (TILs)-derived IFN-γ, which are termed adaptive immune resistant, was first reported in melanomas by Taube et al. (180) and Abiko et al. (181).